Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sylla G Malvi"'
Autor:
Richard Muwonge, Partha Basu, Tarik Gheit, Devasena Anantharaman, Yogesh Verma, Neerja Bhatla, Smita Joshi, Pulikottil O Esmy, Usha Rani Reddy Poli, Anand Shah, Eric Zomawia, Surendra S Shastri, Sharmila Pimple, Priya R Prabhu, Sanjay Hingmire, Aruna Chiwate, Catherine Sauvaget, Eric Lucas, Sylla G Malvi, Maqsood Siddiqi, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Uma Divate, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Massimo Tommasino, M Radhakrishna Pillai, Rengaswamy Sankaranarayanan, Kasturi Jayant, Indian HPV vaccine study group
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244242 (2020)
In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific pre
Externí odkaz:
https://doaj.org/article/e92f5124008247559d15fd87331c1b42
Autor:
Neerja Bhatla, Richard Muwonge, Sylla G. Malvi, Smita Joshi, Usha Rani Reddy Poli, Eric Lucas, Pulikkottil O. Esmy, Yogesh Verma, Anand Shah, Eric Zomawia, Sharmila Pimple, Kasturi Jayant, Sanjay Hingmire, Aruna Chiwate, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Maqsood Siddiqi, Devasena Anantharaman, Gitika Panicker, Julia Butt, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Purnima Kartha, M. Radhakrishna Pillai, Tim Waterboer, Martin Müller, Peter Sehr, Elizabeth R. Unger, Rengaswamy Sankaranarayanan, Partha Basu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTLong-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric study allowed us to compare antibody responses between the younge
Externí odkaz:
https://doaj.org/article/04a82d9a420242adaf6971141ec56cbe
Autor:
Partha Basu, Richard Muwonge, Neerja Bhatla, Bhagwan M. Nene, Smita Joshi, Pulikottil O. Esmy, Usha Rani Reddy Poli, Geeta Joshi, Yogesh Verma, Eric Zomawia, Surendra S. Shastri, Sharmila Pimple, Devasena Anantharaman, Priya R. Prabhu, Sanjay Hingmire, Catherine Sauvaget, Eric Lucas, Michael Pawlita, Tarik Gheit, Kasturi Jayant, Sylla G. Malvi, Maqsood Siddiqi, Angelika Michel, Julia Butt, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Uma Divate, Martina Willhauck-Fleckenstein, Tim Waterboer, Martin Müller, Peter Sehr, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Ranjit Thorat, Massimo Tommasino, M. Radhakrishna Pillai, Rengaswamy Sankaranarayanan
Publikováno v:
Papillomavirus Research, Vol 7, Iss , Pp 75-81 (2019)
Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the quadrivalent Human Papillomavirus (HPV) vaccine in India amongst unmarried girls demonstrated non-inf
Externí odkaz:
https://doaj.org/article/ecef85715e954f86b7b6a1d1f4f5fdaa
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
Autor:
Smita, Joshi, Devasena, Anantharaman, Richard, Muwonge, Neerja, Bhatla, Gitika, Panicker, Julia, Butt, Usha, Rani Reddy Poli, Sylla G, Malvi, Pulikkottil O, Esmy, Eric, Lucas, Yogesh, Verma, Anand, Shah, Eric, Zomawia, Sharmila, Pimple, Kasturi, Jayant, Sanjay, Hingmire, Aruna, Chiwate, Uma, Divate, Shachi, Vashist, Gauravi, Mishra, Radhika, Jadhav, Maqsood, Siddiqi, Subha, Sankaran, Thiraviam, Pillai Rameshwari Ammal Kannan, Purnima, Kartha, Surendra S, Shastri, Catherine, Sauvaget, M, Radhakrishna Pillai, Tim, Waterboer, Martin, Müller, Peter, Sehr, Elizabeth R, Unger, Rengaswamy, Sankaranarayanan, Partha, Basu
Publikováno v:
Vaccine. 41:236-245
The recent World Health Organization recommendation supporting single-dose of HPV vaccine will significantly reduce programmatic cost, mitigate the supply shortage, and simplify logistics, thus allowing more low- and middle-income countries to introd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030ffaf9620373d89d5e9cc3cde20e49
https://doi.org/10.1016/j.vaccine.2022.11.044
https://doi.org/10.1016/j.vaccine.2022.11.044
Autor:
Neerja Bhatla, Bhagwan M. Nene, Smita Joshi, Pulikottil O. Esmy, Usha Rani Reddy Poli, Geeta Joshi, Yogesh Verma, Eric Zomawia, Sharmila Pimple, Priya R. Prabhu, Partha Basu, Richard Muwonge, Sanjay Hingmire, Catherine Sauvaget, Eric Lucas, Michael Pawlita, Tarik Gheit, Kasturi Jayant, Sylla G. Malvi, Maqsood Siddiqi, Angelika Michel, Julia Butt, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Uma Divate, Martina Willhauck-Fleckenstein, Tim Waterboer, Martin Müller, Peter Sehr, Alka Kriplani, Gauravi Mishra, Radhika Jadhav, Ranjit Thorat, Massimo Tommasino, M. Radhakrishna Pillai, Rengaswamy Sankaranarayanan
Publikováno v:
Papillomavirus Research, Vol 5, Iss , Pp 163-171 (2018)
Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine targeted HPV infection outcomes were compared between 1795 girls aged 15–18 years receivi
Externí odkaz:
https://doaj.org/article/5b0f50cd85f14ef28dbbd5d15ae6dbed
Autor:
Pulikkottil Okkuru Esmy, Sylla G. Malvi, Tarik Gheit, Massimo Tommasino, Subha Sankaran, Devasena Anantharaman, Shachi Vashist, Rengaswamy Sankaranarayanan, Smita Joshi, Eric Lucas, M. Radhakrishna Pillai, Radhika Jadhav, Uma Divate, Neerja Bhatla, Gauravi A Mishra, Maqsood Siddiqi, Yogesh Verma, Sanjay Hingmire, Kasturi Jayant, Usha Rani Reddy Poli, Richard Muwonge, Surendra S Shastri, Priya R. Prabhu, Anand Shah, Partha Basu, Eric Zomawia, Aruna Chiwate, Sharmila Pimple, Rintu Varghese, Thiraviam Pillai Rameshwari Ammal Kannan, Catherine Sauvaget
Publikováno v:
The Lancet. Oncology
Background A randomised trial designed to compare three and two doses of quadrivalent human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort study after suspension of HPV vaccination in trials by the Indian Governme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffaa04b877f86009f632cadbde9efab8
https://doi.org/10.1016/s1470-2045(21)00453-8
https://doi.org/10.1016/s1470-2045(21)00453-8
Autor:
Tarik, Gheit, Richard, Muwonge, Eric, Lucas, Luisa, Galati, Devasena, Anantharaman, Sandrine, McKay-Chopin, Sylla G, Malvi, Kasturi, Jayant, Smita, Joshi, Pulikkottil O, Esmy, M Radhakrishna, Pillai, Partha, Basu, Rengaswamy, Sankaranarayanan, Massimo, Tommasino
Publikováno v:
Oral Oncology. 136:106244
Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Although the efficacy of the HPV vaccine in preventing the development of cervical pre-malignant lesions has been well demonstrated, the efficacy of the H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c66e34eb4bd7a0b41591712ad5ce711
https://doi.org/10.1016/j.oraloncology.2022.106244
https://doi.org/10.1016/j.oraloncology.2022.106244
Autor:
Kasturi, Jayant, Rengaswamy, Sankaranarayanan, Ranjit V, Thorat, Richard, Muwonge, Sanjay J, Hingmire, Nandkumar S, Panse, Surendra S, Shastri, Sylla G, Malvi, Bhagwan, Nene
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Objectives: To describe the survival experience of cervix cancer patients in a screened rural population in India. Methods: Included 558 cervical cancer patients diagnosed in 2000-2013 in a cohort of 100,258 women invited for screening during 2000-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d92e8bba9668bd5b429129bd0322938
https://pubmed.ncbi.nlm.nih.gov/28030908
https://pubmed.ncbi.nlm.nih.gov/28030908
Autor:
Richard Muwonge, Sylla G. Malvi, Ramani S Wesley, Somanathan Thara, Surendranath Srinivas Shastri, Kasturi Jayant, Bhagwan M. Nene, Rengaswamy Sankaranarayanan
Publikováno v:
International Journal of Cancer. 134:2902-2909
Although virtually all cervical cancers and most cervical intraepithelial neoplasia (CIN) are caused by persistent human papillomavirus (HPV) infection, only a small proportion of HPV-positive women have or will develop CIN. Triaging HPV-positive wom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85e4ece211ae162dfbd939e6ea9ebefc
https://doi.org/10.1002/ijc.28627
https://doi.org/10.1002/ijc.28627
Autor:
Kasturi Jayant, Bhagwan M. Nene, Vanessa Tenet, Kedar Deodhar, Salvatore Vaccarella, Tarik Gheit, Jose Jeronimo, Sylla G. Malvi, Bakary S. Sylla, Rengaswamy Sankaranarayanan, Christine Carreira Romao, Massimo Tommasino, Silvia Franceschi, Surendra S Shastri, Rohini Kelkar
Publikováno v:
Journal of Medical Virology; Vol 84
Cervical cancer is the most common cancer among women in many areas of India which contributes for a fifth of the global burden of disease. Persistent infection with one of the high-risk human papillomaviruses (HPV) has been established as the cause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87569e4e5f65c21e0a0c2ac4087a5037